Home/Filings/4/0001127602-11-007734
4//SEC Filing

ALLOS THERAPEUTICS INC 4

Accession 0001127602-11-007734

CIK 0001097264operating

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 5:27 PM ET

Size

6.9 KB

Accession

0001127602-11-007734

Insider Transaction Report

Form 4
Period: 2011-02-23
BENNETT BRUCE K JR
VP, Manufacturing
Transactions
  • Sale

    Common Stock

    2011-02-24$3.20/sh1,469$4,70195,915 total
  • Sale

    Common Stock

    2011-02-23$3.23/sh4,484$14,48697,384 total
Footnotes (2)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan under which Mr. Bennett sold a portion of his holdings for tax and estate planning purposes.
  • [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $3.23 to $3.24. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.

Issuer

ALLOS THERAPEUTICS INC

CIK 0001097264

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001097264

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:27 PM ET
Size
6.9 KB